Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-metastatic Patients With Colon Cancer”

224 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 224 results

Testing effectiveness (Phase 2)Ended earlyNCT02842580
What this trial is testing

De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 21
Early research (Phase 1)Study completedNCT01124630
What this trial is testing

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo 21
Large-scale testing (Phase 3)Study completedNCT00952029
What this trial is testing

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 492
Not applicableNot Yet RecruitingNCT07811453
What this trial is testing

Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options

Who this might be right for
Colorectal NeoplasmsLiver NeoplasmsNeoplasm Metastases+2 more
Charite University, Berlin, Germany 260
Testing effectiveness (Phase 2)Looking for participantsNCT07030257
What this trial is testing

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more
Tasca Therapeutics 150
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Looking for participantsNCT07397338
What this trial is testing

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid TumorsNon-small Cell Lung Cancer (NSCLC)+3 more
Revolution Medicines, Inc. 370
Early research (Phase 1)Study completedNCT03689192
What this trial is testing

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more
Herlev Hospital 13
Testing effectiveness (Phase 2)Study completedNCT00910676
What this trial is testing

Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors

Who this might be right for
Metastatic Colorectal CancerNon-Small-Cell Lung Carcinoma
Centre Oscar Lambret 30
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Testing effectiveness (Phase 2)Looking for participantsNCT07020221
What this trial is testing

VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon Small Cell Lung CancerColorectal Cancer+2 more
Verastem, Inc. 295
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Early research (Phase 1)Study completedNCT02860780
What this trial is testing

Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic CancerColorectal Cancer+1 more
Eli Lilly and Company 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06967155
What this trial is testing

Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Blokhin's Russian Cancer Research Center 23
Large-scale testing (Phase 3)Study completedNCT01640405
What this trial is testing

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 350
Large-scale testing (Phase 3)Ended earlyNCT00544700
What this trial is testing

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 265
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT02119026
What this trial is testing

Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Prof. Dr. Werner Scheithauer 120
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Not applicableEnded earlyNCT03328065
What this trial is testing

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

Who this might be right for
Non-resectable Metastatic Cancer of the LungNon-resectable Metastatic Cancer of the ColonNon-resectable Metastatic Cancer of the Rectosigmoid Junction+5 more
Centre Hospitalier Universitaire Dijon
Next Page
36